Inactive Instrument

Iomai Corporation Stock

US46202P1030

Intercell USA, Inc. provides products for the delivery of vaccines to the skin through a proprietary technology known as transcutaneous immunization, or TCI. The Company is evaluating skin immunization techniques in several human clinical trials, including those to prevent influenza in the healthy adult and elderly populations, and also to prevent travelers' diarrhea and anthrax infection.

Employees

Sector

Pharmaceuticals

More about the company

As early as today, start finding the best investment opportunities!

Manager	Title	Age	Since
Franck Grimaud PRN	Corporate Officer/Principal	59	2015-11-30
Reinhard Kandera DFI	Director of Finance/CFO	56	-
Robert C. Seid PRN	Corporate Officer/Principal	-	2008-07-31

Director	Title	Age	Since
Thomas Martin Vernon BRD	Director/Board Member	87	2006-07-04
F. Weller Meyer BRD	Director/Board Member	83	2005-12-31
Richard Douglas BRD	Director/Board Member	73	2001-12-31

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MODERNA, INC.	+2.08%	+29.11%	+712.09%	+100.00%	79.4B
REGENERON PHARMACEUTICALS, INC.	-1.00%	+0.41%	+39.75%	-5.35%	78.69B
CSL LIMITED	+2.15%	+1.41%	-9.14%	-28.26%	59.52B
UCB	+1.18%	+3.03%	+8.89%	+172.84%	46.58B
SAMSUNG BIOLOGICS CO.,LTD.	-1.80%	-2.29%	-11.16%	+30.46%	46.53B
BIOGEN INC.	+0.55%	+5.61%	+65.68%	-11.62%	33.63B
INCYTE CORPORATION	-0.44%	-1.13%	+49.81%	+109.59%	25.11B
INNOVENT BIOLOGICS, INC.	-3.56%	-6.20%	+2.62%	+140.73%	22.13B
SWEDISH ORPHAN BIOVITRUM AB	+0.05%	-2.42%	+60.01%	+99.18%	15.31B
Average	-0.10%	+4.05%	+102.06%	+67.51%	45.21B
Weighted average by Cap.	+0.28%	+6.45%	+155.95%	+54.81%

Iomai Corporation Stock

Stocks

US46202P1030

Pharmaceuticals

Managers and Directors: Iomai Corporation

Biopharmaceuticals

Company Profile

End-of-day quote Nasdaq
-	-